Introduction:Aibo Biotech obtained a round C investment of 700 million US dollars; Tuopu Technology completed round C financing of 500 million yuan; Dipper Technology obtained 100 million USD round B financing
[Investment and Financing Newseight20 - 22]AIBO Bio is a new nucleic acid drug R&D company, committed to the research and development of new drugs based on nucleic acids (siRNA, mRNA, DNA), and the target diseases include cancer and infectious diseases.companyThe total amount announced to be completed a few days ago exceeded 7YimeiRound C of RMBfinancing。
Tuopu Technology is a high-end manufacturing technology enterprise committed to providing intelligent manufacturing equipment and process solutions for aerospace enterprises. The products are mainly used in the field of aerospace vehicle production, including five axis linkage CNC machine tools, aerospace department/assembly intelligent equipment and intelligent production lines. Recently announced the completion of 500 million yuan round C financing.
Dipp Technology is a full scene data intelligent technology company. Based on data intelligence technology, the company has penetrated outstanding digital capabilities into various industry scenarios, and supported enterprises to achieve digital transformation breakthrough from strategy to technology implementation. Recently, it was announced to complete the round B financing of 100 million US dollars.
